Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manushyaa Blossom is a GMP-certified pharmaceutical company based in Tamil Nadu, India, specializing in the development and manufacturing of Siddha nano-bio formulations and herbo-mineral medicines. The company bridges ancient traditional Siddha medical literature with modern scientific practices, utilizing advanced analytical instruments and clinical studies. Manushyaa Blossom focuses on treating complex and unresolved health conditions, including neurodevelopmental disorders like autism spectrum disorder (ASD) and ADHD, as well as autoimmune and chronic diseases. Additionally, the company operates a multi-specialty Siddha clinic in Chennai and has developed an AI-based diagnostic tool to identify autism at birth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manushyaa Blossom.